Health

d3671d3f6ed9

One disease, two lives

A drug offering a last resort for many patients with extensively drug resistant tuberculosis (DR-TB) remains unavailable to desperately ill South Africans as the country'€™s drug regulatory body continues to delay compassionate access. Health-e News Service tells the story of two young South Africans, one who managed to beat the system and accessBedaquiline, the other coming up against a brick wall and fast running out of options to save her life. By Anso Thom, Health-e News Service

Read More » One disease, two lives

Newsletter Subscription

Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.

  • This field is for validation purposes and should be left unchanged.
Enable Notifications OK No thanks